Mechanisms and disease consequences of nonalcoholic fatty liver disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33989548.
- Also identified by DOI 10.1016/j.cell.2021.04.015 and PMC identifier 12168897.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the leading chronic liver disease worldwide. Its more advanced subtype, nonalcoholic steatohepatitis (NASH), connotes progressive liver injury that can lead to cirrhosis and hepatocellular carcinoma. Here we provide an in-depth discussion of the underlying pathogenetic mechanisms that lead to progressive liver injury, including the metabolic origins of NAFLD, the effect of NAFLD on hepatic glucose and lipid metabolism, bile acid toxicity, macrophage dysfunction, and hepatic stellate cell activation, and consider the role of genetic, epigenetic, and environmental factors that promote fibrosis progression and risk of hepatocellular carcinoma in NASH.
Medical subject headings
- Carcinoma, Hepatocellular
- Liver Neoplasms
- Non-alcoholic Fatty Liver Disease